Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Kava

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Urology|August 27, 2017
Reclassification Rates of Patients Eligible for Active Surveillance After the Addition of Magnetic Resonance Imaging-Ultrasound Fusion Biopsy: An Analysis of 7 Widely Used Eligibility CriteriaBruno Nahar, Andrew Katims, Marcelo Panizzutti Barboza, et al.
Urology Case Reports|May 23, 2018
Malakoplakia of the prostate diagnosed on multiparametric-MRI ultrasound fusion guided biopsy: A case report and review of the literatureMaria C Velasquez, Paul J Taylor Smith, Nachiketh Soodana Prakash, et al.
Clinical Genitourinary Cancer|December 28, 2024
Impact of BMI Category on Recurrence and Progression of Nonmuscle Invasive Bladder Cancer PrognosisJamie Thomas, Aakangsha Jain, Ram Hirpara, et al.
Urologic Oncology|August 6, 2023
A multi-institutional study of 1,111 men with 4K score, multiparametric magnetic resonance imaging, and prostate biopsyJamie Thomas, Shrikanth Atluri, Isaac Zucker, et al.
The Journal of Urology|December 28, 2020
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted BiopsySanoj Punnen, Radka Stoyanova, Deukwoo Kwon, et al.
Urologic Oncology|April 9, 2026
Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancerSeyed Hossein Hosseini Sharifi, Jonathan T Ryan, Adam Williams, et al.
BJU International|May 6, 2026
Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trialSeyed Hossein Hosseini Sharifi, Adam Williams, Jonathan T Ryan, et al.
The Journal of Sexual Medicine|June 25, 2026
Impact of testosterone therapy and hypogonadism on treatment outcomes in Peyronie's disease: a multicenter retrospective analysis of collagenase clostridium histolyticum therapyBeatriz S Hernandez, Arnaav Walia, Peyton Coady, et al.
BJU International|February 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)Ankur Malpani, Jonathan T Ryan, Hui Yu, et al.
European Urology Focus|December 12, 2024
Assessing the Molecular Heterogeneity of Prostate Cancer Biopsy Sampling: Insights from the MAST TrialTarek Ajami, Hui Yu, Joao G Porto, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Urology|August 27, 2017
Reclassification Rates of Patients Eligible for Active Surveillance After the Addition of Magnetic Resonance Imaging-Ultrasound Fusion Biopsy: An Analysis of 7 Widely Used Eligibility CriteriaBruno Nahar, Andrew Katims, Marcelo Panizzutti Barboza, et al.
Urology Case Reports|May 23, 2018
Malakoplakia of the prostate diagnosed on multiparametric-MRI ultrasound fusion guided biopsy: A case report and review of the literatureMaria C Velasquez, Paul J Taylor Smith, Nachiketh Soodana Prakash, et al.
Clinical Genitourinary Cancer|December 28, 2024
Impact of BMI Category on Recurrence and Progression of Nonmuscle Invasive Bladder Cancer PrognosisJamie Thomas, Aakangsha Jain, Ram Hirpara, et al.
Urologic Oncology|August 6, 2023
A multi-institutional study of 1,111 men with 4K score, multiparametric magnetic resonance imaging, and prostate biopsyJamie Thomas, Shrikanth Atluri, Isaac Zucker, et al.
The Journal of Urology|December 28, 2020
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted BiopsySanoj Punnen, Radka Stoyanova, Deukwoo Kwon, et al.
Urologic Oncology|April 9, 2026
Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancerSeyed Hossein Hosseini Sharifi, Jonathan T Ryan, Adam Williams, et al.
BJU International|May 6, 2026
Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trialSeyed Hossein Hosseini Sharifi, Adam Williams, Jonathan T Ryan, et al.
The Journal of Sexual Medicine|June 25, 2026
Impact of testosterone therapy and hypogonadism on treatment outcomes in Peyronie's disease: a multicenter retrospective analysis of collagenase clostridium histolyticum therapyBeatriz S Hernandez, Arnaav Walia, Peyton Coady, et al.
BJU International|February 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)Ankur Malpani, Jonathan T Ryan, Hui Yu, et al.
European Urology Focus|December 12, 2024
Assessing the Molecular Heterogeneity of Prostate Cancer Biopsy Sampling: Insights from the MAST TrialTarek Ajami, Hui Yu, Joao G Porto, et al.
Pageof 4